University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Sarah Arron, Ph.D., M.D.

Dermatologic surgeon

Dr. Sarah Arron, a dermatologic surgeon, is director of the High Risk Skin Cancer Program, which cares for patients who are at risk for skin cancer due to organ transplant, leukemia, lymphoma or genetic syndromes. She specializes in an advanced procedure called Mohs micrographic surgery to treat certain types of skin cancer. Arron also is an expert in facial reconstruction following surgery, laser surgery, dermatology for organ transplant recipients and for those with genetic risk factors for skin cancer. In addition, she performs cosmetic procedures including Botox and soft tissue fillers.

Arron's research interests include studying skin cancer, particularly in patients who are immunosuppressed. She earned a medical degree at Weill Medical College of Cornell University and a doctorate at The Rockefeller University. She completed a residency in dermatology and a fellowship in Mohs micrographic surgery and procedural dermatology at UCSF. Arron is an assistant professor in residence of dermatology at UCSF and the Helen Diller Family Comprehensive Cancer Center.

Clinics

Dermatologic Surgery and Laser Center
1701 Divisadero St.
San Francisco, CA 94115
Phone: (415) 353–7878
Fax: (415) 353–7838

Hours: Monday to Friday, 8 a.m. – 5 p.m.

High Risk Skin Cancer Clinic
1701 Divisadero St., Third Floor
San Francisco, CA 94143-0316
Phone: (415) 353-7878
Fax: (415) 353-7860

Hours: Friday by appointment

Melanoma Center
1600 Divisadero St.,
San Francisco, CA 94115
Phone: (415) 353-9900
Fax: (415) 885-3802

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

More about Sarah Arron

Education

Cornell University School of Medicine 2003

Residencies

UCSF Medical Center, Dermatology 2008

Fellowships

UCSF Medical Center, Procedural Dermatology 2007

Selected Research and Publications

  1. Binstock M, Hafeez F, Metchnikoff C, Arron ST. Single-nucleotide polymorphisms in pigment genes and nonmelanoma skin cancer predisposition: a systematic review. Br J Dermatol. 2014 Oct; 171(4):713-21.
  2. Gupta R, Michaud HA, Zeng X, Debbaneh M, Arron ST, Jones RB, Ormsby CE, Nixon DF, Liao W. Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasis. J Transl Med. 2014; 12(1):256.
  3. Dybbro E, Fordyce P, Ponte M, Arron ST. Hydraulic expulsion of tumbu fly larvae. JAMA Dermatol. 2014 Jul; 150(7):791-2.
  4. Arron ST, Canavan T, Yu SS. Organ transplant recipients with Merkel cell carcinoma have reduced progression-free, overall, and disease-specific survival independent of stage at presentation. J Am Acad Dermatol. 2014 Oct; 71(4):684-90.
  5. He SY, McCulloch CE, Boscardin WJ, Chren MM, Linos E, Arron ST. Self-reported pigmentary phenotypes and race are significant but incomplete predictors of Fitzpatrick skin phototype in an ethnically diverse population. J Am Acad Dermatol. 2014 Oct; 71(4):731-7.
  6. Mavropoulos JC, Aldabagh B, Arron ST. Prospects for personalized targeted therapies for cutaneous squamous cell carcinoma. Semin Cutan Med Surg. 2014 Jun; 33(2):72-5.
  7. Yu J, Aldabagh B, Wang J, Yom SS, El-Sayed I, Knott D, McGrath MH, Arron S. Multidisciplinary management of advanced Basal cell carcinoma: report of four cases. J Drugs Dermatol. 2014 May 1; 13(5):601-6.
  8. Wang J, Aldabagh B, Yu J, Arron ST. Role of human papillomavirus in cutaneous squamous cell carcinoma: A meta-analysis. J Am Acad Dermatol. 2014 Apr; 70(4):621-9.
  9. South AP, Purdie KJ, Watt SA, Haldenby S, den Breems NY, Dimon M, Arron ST, Kluk MJ, Aster JC, McHugh A, Xue DJ, Dayal JH, Robinson KS, Rizvi SM, Proby CM, Harwood CA, Leigh IM. NOTCH1 Mutations Occur Early during Cutaneous Squamous Cell Carcinogenesis. J Invest Dermatol. 2014 Oct; 134(10):2630-8.
  10. Arron ST, Dimon MT, Li Z, Johnson ME, A Wood T, Feeney L, G Angeles J, Lafyatis R, Whitfield ML. High Rhodotorula sequences in skin transcriptome of patients with diffuse systemic sclerosis. J Invest Dermatol. 2014 Aug; 134(8):2138-45.
  11. Sanchez Rodriguez R, Pauli ML, Neuhaus IM, Yu SS, Arron ST, Harris HW, Yang SH, Anthony BA, Sverdrup FM, Krow-Lucal E, Mackenzie TC, Johnson DS, Meyer EH, Löhr A, Hsu A, Koo J, Liao W, Gupta R, Debbaneh MG, Butler D, Huynh M, Levin EC, Leon A, Hoffman WY, McGrath MH, Alvarado MD, Ludwig CH, Truong HA, Maurano MM, Gratz IK, Abbas AK, Rosenblum MD. Memory regulatory T cells reside in human skin. J Clin Invest. 2014 Mar 3; 124(3):1027-36.
  12. Dimon MT, Wood HM, Rabbitts PH, Liao W, Cho RJ, Arron ST. No evidence for integrated viral DNA in the genome sequence of cutaneous squamous cell carcinoma. J Invest Dermatol. 2014 Jul; 134(7):2055-7.
  13. Williams K, Mansh M, Chin-Hong P, Singer J, Arron ST. Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients. Clin Infect Dis. 2014 Apr; 58(7):997-1002.
  14. Makhzoumi ZH, Arron ST. Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study. J Invest Dermatol. 2013 Aug; 133(8):1922-3.
  15. Aldabagh B, Yu J, Perkocha LA, Arron S. Histologic changes in Basal cell carcinoma after treatment with vismodegib. Dermatol Surg. 2013 Nov; 39(11):1703-5.
  16. Ally MS, Tang JY, Arron ST. Cutaneous human papillomavirus infection and Basal cell carcinoma of the skin. J Invest Dermatol. 2013 Jun; 133(6):1456-8.
  17. Dimon MT, Wood HM, Rabbitts PH, Arron ST. IMSA: integrated metagenomic sequence analysis for identification of exogenous reads in a host genomic background. PLoS One. 2013; 8(5):e64546.
  18. Mihalis EL, Wysong A, Boscardin WJ, Tang JY, Chren MM, Arron ST. Factors affecting sunscreen use and sun avoidance in a U.S. national sample of organ transplant recipients. Br J Dermatol. 2013 Feb; 168(2):346-53.
  19. Wysong A, Linos E, Hernandez-Boussard T, Arron ST, Gladstone H, Tang JY. Nonmelanoma skin cancer visits and procedure patterns in a nationally representative sample: national ambulatory medical care survey 1995-2007. Dermatol Surg. 2013 Apr; 39(4):596-602.
  20. Gogia R, Binstock M, Hirose R, Boscardin WJ, Chren MM, Arron ST. Fitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantation. J Am Acad Dermatol. 2013 Apr; 68(4):585-91.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.